Activation of IL-6R/JAK1/STAT3 Signaling Induces De Novo Resistance to Irreversible EGFR Inhibitors in Non–Small Cell Lung Cancer with T790M Resistance Mutation
- Mol. Cancer Ther., October 2012 Volume 11, Issue 10 | https://doi.org/10.1158/1535-7163.MCT-12-0311